7,748 12,130 1,777
Prepaid expenses and other
receivables 8,249 9,260 1,357
Deferred tax assets 1,802 2,581 378
Total current assets 824,612 857,246 125,583
Available-for-sale securities 26,700 14,682 2,151
Property, plant and equipment, net 78,185 139,263 20,401
Lease prepayments 8,894 8,629 1,264
Non-current deposits 8,521 15,596 2,285
Intangible assets, net 5,225 4,400 645
Deferred tax assets 781 106 16
Total assets 952,918 1,039,922 152,345
Liabilities
Current liabilities
Accounts payable 1,939 3,062 449
Deferred grant income 374 374 55
Accrued expenses and other payables 25,273 35,569 5,211
Income tax payable 1,256 3,323 487
Other current liabilities 57 -- --
Total current liabilities 28,899 42,328 6,202
Deferred grant income 3,152 2,871 421
Other liabilities 472 -- --
Total liabilities 32,523 45,199 6,623
Commitments and contingencies -- -- --
Shareholders' equity
Share capital - ordinary shares
US$0.0001 par value, 500,000,000
shares authorized, 150,575,955 and
150,635,189 issued and outstanding
as of December 31, 2008 and
September 30, 2009, respectively 121 121 18
Additional paid-in capital 908,3
'/>"/>SOURCE 3SBio Inc. Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 Related biology technology :1.
3SBio Inc. to Report 2009 Third Quarter Earnings on November 12, 20092.
3SBio Inc. to Hold 2009 Annual General Meeting on October 12, 20093.
3SBio Inc. Announces Appointment of Ernst & Young Hua Ming as Independent Auditor4.
3SBio Inc. Announces Unaudited Fourth Quarter and Fiscal Year 2008 Results5.
3SBio Inc. Receives Official Recognition as a High-Tech Enterprise6.
3SBio Inc. to Report 2008 Fourth Quarter and Full Year Earnings on March 11, 20097.
3SBio Inc. Appoints Mr. Bo Tan as Chief Financial Officer8.
3SBio Inc. to Present at the Piper Jaffray 20th Annual Health Care Conference9.
3SBio Inc. Announces Third Quarter 2008 Results10.
3SBio Inc. Files for SFDA Approval of NuLeusin11.
3SBio Inc. Announces Preliminary Third Quarter 2008 Results